These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16208781)

  • 1. Effect of sildenafil citrate on viability of flaps: an experimental study in rats.
    Ayyildiz A; Uysal A; Koçer U; Karaaslan O; Huri E; Germiyanoglu C; Caydere M
    Scand J Plast Reconstr Surg Hand Surg; 2005; 39(4):204-8. PubMed ID: 16208781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved flap viability with site-specific delivery of sildenafil citrate using fibrin glue.
    Ulusoy MG; Uysal A; Koçer U; Karaaslan O; Cuzdan SS; Ayyildiz A; Ustün H
    Ann Plast Surg; 2005 Sep; 55(3):292-6. PubMed ID: 16106170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sildenafil on the viability of random skin flaps.
    Barral SM; Araujo ID; Vidigal PV; Mayrink CA; Araujo AD; Costa PR
    Acta Cir Bras; 2011 Aug; 26(4):314-9. PubMed ID: 21808846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
    Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
    Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation and cGMP formation in response to sildenafil and sodium nitroprusside in saphenous veins from normotensive and hypertensive patients.
    Medina P; Segarra G; Martínez-León JB; Vila JM; Otero E; Lluch S
    Am J Hypertens; 2002 Sep; 15(9):798-802. PubMed ID: 12219875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
    Rosen RC; McKenna KE
    Annu Rev Sex Res; 2002; 13():36-88. PubMed ID: 12836729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
    Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil inhibits agonist-evoked rat uterine contractility: influence of guanylyl cyclase inhibition.
    Agha AM; Taha RA
    Eur J Pharmacol; 2001 Oct; 428(3):343-8. PubMed ID: 11689193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
    Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
    Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
    Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of cardiostimulatory effects of sildenafil.
    Sugiyama A; Takeuchi N; Saegusa Y; Sugita M; Hashimoto K
    Jpn J Pharmacol; 2002 Mar; 88(3):362-4. PubMed ID: 11949894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.
    Devan BD; Bowker JL; Duffy KB; Bharati IS; Jimenez M; Sierra-Mercado D; Nelson CM; Spangler EL; Ingram DK
    Psychopharmacology (Berl); 2006 Jan; 183(4):439-45. PubMed ID: 16320087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sildenafil citrate on the cardiovascular system.
    Shinlapawittayatorn K; Chattipakorn S; Chattipakorn N
    Braz J Med Biol Res; 2005 Sep; 38(9):1303-11. PubMed ID: 16138212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
    Doherty PC; Bivalacqua TJ; Champion HC; Kadowitz PJ; Greenwood-Van Meerveld B; Berzetei-Gurske I; Hellstrom WJ
    J Urol; 2001 Mar; 165(3):1004-9. PubMed ID: 11176530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sildenafil citrate on human hemodynamics.
    Jackson G; Benjamin N; Jackson N; Allen MJ
    Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sildenafil citrate on secondary healing in full thickness skin defects in experiment.
    Cakmak E; Karasoy Yesilada A; Sevim KZ; Sumer O; Tatlidede HS; Sakiz D
    Bratisl Lek Listy; 2014; 115(5):267-71. PubMed ID: 25174056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
    Patil CS; Singh VP; Kulkarni SK
    Inflammopharmacology; 2005; 13(5-6):467-78. PubMed ID: 16280099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of sildenafil on random skin flap survival in rats: an experimental study.
    Sarifakioglu N; Gokrem S; Ates L; Akbuga UB; Aslan G
    Br J Plast Surg; 2004 Dec; 57(8):769-72. PubMed ID: 15544775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.